Faculty Opinions recommendation of Analyzing the human serum antibody responses to a live attenuated tetravalent dengue vaccine candidate.

Author(s):  
Scott Halstead
2018 ◽  
Vol 217 (12) ◽  
pp. 1932-1941 ◽  
Author(s):  
Jesica A Swanstrom ◽  
Sandra Henein ◽  
Jessica A Plante ◽  
Boyd L Yount ◽  
Douglas G Widman ◽  
...  

1987 ◽  
Vol 2 (2) ◽  
pp. 53-59 ◽  
Author(s):  
J. L. Ebersole ◽  
M. A. Taubman ◽  
D. J. Smith ◽  
D. E. Frey ◽  
A. D. Haffajee ◽  
...  

PLoS ONE ◽  
2010 ◽  
Vol 5 (11) ◽  
pp. e13916 ◽  
Author(s):  
Michael Vaine ◽  
Shixia Wang ◽  
Qin Liu ◽  
James Arthos ◽  
David Montefiori ◽  
...  

1996 ◽  
Vol 3 (1) ◽  
pp. 93-97 ◽  
Author(s):  
E Grimprel ◽  
P Bégué ◽  
I Anjak ◽  
E Njamkepo ◽  
P François ◽  
...  

Author(s):  
Isamu Tsuji ◽  
David Dominguez ◽  
Michael A Egan ◽  
Hansi J Dean

Abstract Antibody affinity maturation is a critical step in development of functional antiviral immunity, however, accurate measurement of affinity maturation of polyclonal serum antibody responses to particulate antigens such as virions is challenging. We describe a novel avidity assay employing bio-layer interferometry and dengue virus-like particles. After validation using anti-dengue monoclonal antibodies, the assay was used to assess avidity of antibody responses to a tetravalent dengue vaccine candidate (TAK-003) in children, adolescents and adults during two Phase 2 clinical trials conducted in dengue endemic regions. Vaccination increased avidity index and avidity remained high through one-year post vaccination. Neutralizing antibody titers and avidity index did not correlate overall, however, a correlation was observed between neutralizing antibody titer and avidity index in those subjects with the highest degree of antibody affinity maturation. Therefore, vaccination with TAK-003 stimulates polyclonal affinity maturation and functional antibody responses including neutralizing antibodies.


Sign in / Sign up

Export Citation Format

Share Document